MoneyWorks4Me

Hikal - Quaterly Results

09 May 2024 Evaluate
The sales for the March 2024 quarter moved down to Rs. 5141.00 millions as compared to Rs. 5452.90 millions during the year-ago period.A slender decline of -6.13% was recorded to Rs. 338.60  millions from Rs. 360.70 millions in the corresponding previous quarter.OP of the company witnessed a marginal growth to 948.10 millions from 884.60 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 5141.00 5452.90 -5.72 17846.00 20230.30 -11.79 17846.00 20230.30 -11.79
Other Income 4.60 3.80 21.05 24.50 54.10 -54.71 24.50 54.10 -54.71
PBIDT 948.10 884.60 7.18 2693.90 2624.70 2.64 2693.90 2624.70 2.64
Interest 152.60 129.80 17.57 563.70 481.00 17.19 563.70 481.00 17.19
PBDT 795.50 754.80 5.39 2130.20 2143.70 -0.63 2130.20 2143.70 -0.63
Depreciation 323.40 268.30 20.54 1176.10 1090.10 7.89 1176.10 1090.10 7.89
PBT 472.10 486.50 -2.96 954.10 1053.60 -9.44 954.10 1053.60 -9.44
TAX 133.50 125.80 6.12 259.00 269.80 -4.00 259.00 269.80 -4.00
Deferred Tax -26.40 -21.20 24.53 -24.70 -35.00 -29.43 -24.70 -35.00 -29.43
PAT 338.60 360.70 -6.13 695.10 783.80 -11.32 695.10 783.80 -11.32
Equity 246.60 246.60 0.00 246.60 246.60 0.00 246.60 246.60 0.00
PBIDTM(%) 18.44 16.22 13.68 15.10 12.97 16.35 15.10 12.97 16.35
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..